HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts FibroGen (FGEN) Investors to Filing of Securities Fraud Class Action and Encourages Investors with Losses to Contact Its Attorneys NowNewsfile Corp • 04/14/21
SHAREHOLDER ALERT: FibroGen, Inc. (FGEN) Officers and Directors Under Investigation for False Statements and Insider TradingPRNewsWire • 04/14/21
FIBROGEN ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against FibroGen, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 04/14/21
BREAKING NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages FibroGen, Inc. Investors with Losses to Secure Counsel Before Important Deadline - FGENPRNewsWire • 04/14/21
Berman Tabacco's California Office Files Securities Class Action Lawsuit Against FibroGen, Inc. (FGEN) And Announces June 11, 2021 Lead Plaintiff DeadlineNewsfile Corp • 04/13/21
FGEN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies FibroGen, Inc. Shareholders of Class Action and Encourages Investors to Contact the FirmPRNewsWire • 04/13/21
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of FibroGen Inc. (FGEN) InvestorsBusiness Wire • 04/13/21
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages FibroGen, Inc. Investors with Losses to Secure Counsel Before Important Deadline – FGENBusiness Wire • 04/13/21
Berman Tabacco Files Securities Class Action Lawsuit Against FibroGen, Inc. (FGEN)Newsfile Corp • 04/12/21
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against FibroGen, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmPRNewsWire • 04/09/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages FibroGen (FGEN) Investors with Losses to Contact Its Attorneys Now, Company Admits to Manipulating Data for Anemia DrugNewsfile Corp • 04/09/21
FIBROGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating FibroGen, Inc. on Behalf of FibroGen Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 04/09/21
Scott+Scott Attorneys at Law LLP Announces Investigation into FibroGen, Inc. (FGEN)Business Wire • 04/08/21
Berman Tabacco Investigates Potential Securities Law Violations By California-Based FibroGen Inc. (FGEN) In Connection with Roxadustat "Clarification"Newsfile Corp • 04/08/21
EQUITY ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of FibroGen, Inc.Newsfile Corp • 04/08/21
FGEN Stock: Berger Montague Investigates Potential Securities Fraud Claims Against FibroGen, Inc. (FGEN) For Manipulating Drug DataNewsfile Corp • 04/08/21
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against FibroGen, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 04/08/21
INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against FibroGen Inc.Business Wire • 04/07/21
The Law Offices of Frank R. Cruz Continues Its Investigation of FibroGen Inc. (FGEN) on Behalf of InvestorsBusiness Wire • 04/07/21
INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against FibroGen, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 04/07/21
FibroGen plunges 43% after the company says there were errors in safety analyses data for its anemia drug candidate (FGEN)Business Insider • 04/07/21
Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of FibroGen Inc. (FGEN) on Behalf of InvestorsBusiness Wire • 04/07/21
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of FibroGen Inc. (FGEN) on Behalf of InvestorsBusiness Wire • 04/07/21